Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3

Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3

US Patent 11046764 · Granted Jun 29, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies useful in passive influenza immunization, and compositions, combinati2025
Antibodies useful in passive influenza immunization, and compositions, combinati2025
Engineered CD25 polypeptides and uses thereof2025
Immunogen providing an extended protective lifetime against respiratory syncytia2025
Binding moieties for biofilm remediation2024
Binding moieties for biofilm remediation2024
Binding moieties for biofilm remediation2024
Drug regimen for treatment of cerebral ischemia2024
Conformational epitopes in respiratory syncytial virus G protein central conserv2023
Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family2023
Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family2023
Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family2023